Engaged in diverse basic, translational and clinical research, our faculty routinely publish in prestigious journals and successfully compete for major grants from national funders.
A phase 3 double-blind study to evaluate the efficacy and safety of oral ozanimod compared to oral fingolimod in children and adolescents with relapsing-remitting multiple sclerosis. Michael Dwyer, III (Co-Investigator). Bristol Myers Squibb. $1,649,376. 6/1/2023-12/1/2032.
Clinical and Translational Sciences Institute. Ram Samudrala (Co-Investigator). National Center for Advancing Translational Sciences. $28,400,000. 1/1/2026-12/1/2032.
CTSA State University of New York at Buffalo. Zackary Falls (Contributor). National Center for Advancing Translational Sciences (NCATS). $29,204,726. 1/1/2025-12/1/2031.
Clinical and Translational Science Award. Core Operations Special Populations. Ralph Benedict (Co-Investigator). NIH. $29,204,726. 1/1/2025-12/1/2031.
CTSA UM1 State University of New York at Buffalo. Bonnie Vest (Other). NIH. 1/1/2025-12/1/2031.
CTSA UM1 State University of New York at Buffalo. Praveen Chandrasekharan (Co-Investigator). NIH/NCATS. $29,204,726. 8/1/2025-7/1/2031.
CTSA UM1 State University of New York at Buffalo. Gabriela Popescu (Co-Investigator). National Center for Advancing Translational Sciences. $3,710,000. 1/1/2025-1/1/2031.
The UB Primary Care Training and Enhancement – Residency Training in Street Medicine. Brian Clemency (Co-Investigator). HRSA. $2,500,000. 9/1/2025-9/1/2030.
Structure and assembly of membrane proteins at tight junctions. Alex Vecchio (Principal Investigator). NIH/NIGMS. $2,166,105. 9/1/2025-8/1/2030.
Revolutionizing Protein Structure Determination with Advanced SWAXS Analysis. Thomas Grant (Principal Investigator). NIH NIGMS. $2,181,805. 8/1/2025-7/1/2030.
Prevention of Postpartum Smoking Relapse and Related Health Consequences by Breastfeeding Promotion. Xiaozhong Wen (Principal Investigator). National Institute of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development. $3,361,314. 8/1/2025-7/1/2030.
CTSA K12 Program State University of New York at Buffalo. Praveen Chandrasekharan (Co-Investigator). NIH/NCATS. $3,269,012. 6/1/2025-7/1/2030.
Prevention of Postpartum Smoking Relapse and Related Health Consequences through Breastfeeding Promotion. Praveen Chandrasekharan (Co-Principal Investigator). NICHD. $3,841,280. 8/1/2025-7/1/2030.
Impact of polymicrobial interactions and within-host adaptation on CAUTI pathogenesis. Chelsie Armbruster (Principal Investigator). NIDDK. $3,693,751. 7/1/2025-6/1/2030.
Impact of “Institutions for Mental Diseases” (IMD) Medicaid waivers on opioid use disorder treatment outcomes: A Mixed Methods Approach to Identify Strategies that Improve Utilization and Quality of Care and Promote Equity in Treatment. Heather Gardiner (Other). NIH. $945,788. 7/1/2025-6/1/2030.